Chicagoland Diabetes TrialNet Clinical Center

芝加哥糖尿病 TrialNet 临床中心

• 批准号: 9414298
• 负责人: Louis H. Philipson
• 金额: $ 4.92万
• 依托单位: UNIVERSITY OF CHICAGO
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-05 至 2019-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9414298
• 关键词: Adult; Advocate; Affect; American; Area; Autoimmune Diseases; Caring; Chicago; Childhood; Clinical; Clinical Trials; Communication; Communities; Country; Databases; Diabetes Mellitus; Endocrinology; Enrollment; Ensure; Event; Family; Family member; Foundations; Geographic Locations; Group Practice; Health; Healthcare; Hour; Illinois; Individual; Institution; Insulin-Dependent Diabetes Mellitus; Joints; Location; Longevity; Medical center; Methods; Midwestern United States; Patients; Pediatric Hospitals; Persons; Population; Recruitment Activity; Registries; Research; Resources; Risk; Site; Socioeconomic Status; United States; Universities; Visit; clinical care; cost; cost effective; data sharing; experience; follow-up; innovation; lost earning; metropolitan; outreach; public health relevance; racial diversity; response; screening; social media; success; young adult

DESCRIPTION (provided by applicant): This application "Chicagoland TrialNet Clinical Center" is in response to the RFA -DK-13-010 Type 1 Diabetes TrialNet Clinical Centers (U01). Here we describe a joint effort from the University of Chicago and Advocate Children's Hospital (ACH) sites (Park Ridge and Oak Lawn, Illinois) and Advocate Health Care (AHC) to create a new Clinical Center in the Chicagoland area. These organizations along with our other affiliate (Lurie Children's Hospital) and partner sites saw over 9000 patients with type 1 diabetes (T1D) in 2012. Together, these practice sites along with other participating key adult and pediatric diabetes practitioners from Chicago reach over 12 million individuals within a two-hour drive of a screening location. The Chicago community, strong supporters of the Juvenile Diabetes Research Foundation (JDRF) and American Diabetes Association (ADA), has been under-represented in clinical trials for Type 1 Diabetes (T1D). This partnership will bring together the resources of major medical centers committed to T1D research and clinical care to reach more of the estimated 100,000 individuals with T1D in the Chicagoland area (about 0.8% of the area population) and their families, as well as the 2000 projected new cases of T1D and their families each year. This outreach will involve diverse communities from some of the wealthiest to some of the most underserved in the United States. We will build on our success in creating the largest database for monogenic diabetes in the United States. We will engage the greater Chicagoland community through innovative social media and direct communications combining media support, direct visits to local practices, community events supported by our institutions and partners and outreach to large networks of faith communities. The University of Chicago has been committed to diabetes research for over 100 years, and together with Advocate Children's Hospital and other partners we will bring a new sense of energy, organization, and purpose to TrialNet recruitment and screening in the Chicagoland region.

描述（由申请人提供）：此申请“芝加哥试验网临床中心”是对RFA -DK-13-010 1型糖尿病试验网络临床中心（U01）的响应。在这里，我们描述了芝加哥大学和倡导者儿童医院（ACH）（伊利诺伊州的Park Ridge and Oak Lawn）的共同努力，并提倡医疗保健（AHC），以在芝加哥地区创建一个新的临床中心。这些组织以及我们的其他会员（Lurie儿童医院）和合作伙伴网站在2012年看到了9000多名1型糖尿病（T1D）患者。在两个小时的筛选地点，这些练习场所以及来自芝加哥的其他参与的主要成人和儿科糖尿病从业人员都可以在两个小时的筛选地点范围内获得超过1200万个人。芝加哥社区，少年糖尿病研究基金会（JDRF）和美国糖尿病协会（ADA）的强大支持者，在1型糖尿病（T1D）的临床试验中的代表性不足。该伙伴关系将汇集致力于T1D研究和临床护理的主要医疗中心的资源，以吸引芝加哥地区估计有100,000名T1D的人中的更多人（约占该地区人口的0.8％）及其家人，以及2000年预计每年的T1D案件及其家人。这种宣传将涉及从一些最富有的社区到美国最乏味的社区。我们将在创建美国单基因糖尿病的最大数据库方面取得成功。我们将通过创新的社交媒体和直接沟通来吸引大型芝加哥社区，结合媒体支持，直接访问当地实践，我们的机构和合作伙伴支持的社区活动，以及向大型信仰社区网络推广。芝加哥大学一直致力于糖尿病研究已有100多年的历史，并与倡导者儿童医院和其他合作伙伴一起，我们将带来新的能量，组织和目的感，以在芝加哥地区招募和筛查。